DSIP

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide consisting of nine amino acids with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. First identified in 1977 from cerebral venous blood of rabbits during electrically induced sleep by Swiss researchers Schoenenberger and Monnier, DSIP has since been studied for its role in sleep architecture regulation, stress response modulation, and neuroendocrine activity. Research has examined DSIP's effects on circadian rhythm regulation, its interactions with the hypothalamic-pituitary axis, and its potential influence on cortisol and ACTH levels during stress responses. Studies have documented effects on delta wave sleep patterns, from which the peptide derives its name. DSIP research extends beyond sleep physiology into areas including opioid receptor modulation, withdrawal symptom attenuation, and free radical scavenging activity. The peptide's stability in serum and its ability to cross the blood-brain barrier make it a practical research tool in sleep physiology and chronobiology. Its effects on reducing corticotropin levels suggest involvement in stress-adaptive pathways, adding complexity to its pharmacological profile beyond simple sleep induction.